FDA COX-2 Review Will Include Input From Furberg, Full Rx Safety Advisory Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
After initially being asked not to appear at the meeting, Wake Forest's Furberg is formally re-invited to participate at the Feb 16-18 advisory committee meeting. FDA first invited only two members of the drug safety committee but has expanded its invitation to the full committee.